Alpine Global Management’s Northwest Biotherapeutics NWBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-110,187
Closed -$64K – 251
2016
Q2
$64K Buy
+110,187
New +$118K 0.03% 154

Other funds holding NWBO

Alpine Global Management's NWBO Position: Q3 2016 in Review

Alpine Global Management sold out of Northwest Biotherapeutics (NWBO) in Q3 2016, closing a stake of 110,187 shares — an estimated $64K sold.

Alpine Global Management first reported a position in NWBO in Q2 2016 and held it in 1 quarter. The position peaked at $64K in Q2 2016. 54 funds tracked by Wall St. Rank hold NWBO as of Q3 2016.

  • Alpine Global Management reported no remaining Northwest Biotherapeutics position as of Q3 2016 after selling out during the quarter.
  • Alpine Global Management sold 110,187 Northwest Biotherapeutics shares in Q3 2016, an estimated $64K.
  • Alpine Global Management first reported a position in Northwest Biotherapeutics in Q2 2016 and held it in 1 quarter.
  • Alpine Global Management's Northwest Biotherapeutics position peaked at $64K in Q2 2016.
  • 54 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q3 2016.

Based on Alpine Global Management's 13F filing for Q3 2016, filed 15 Nov 2016.